Varian Medical (NYSE:VAR) said today it won Shonin approval from the Japanese Ministry of Health, Labor and Welfare for its Halcyon image-guided volumetric intensity modulated radiotherapy cancer treatment system. The Palo Alto, Calif.-based company said its Halcyon IMRT system features improvements that make it more comfortable for patients and streamline operator’s workflow, only requiring 9 steps […]
Oncology
OncoSec Medical lands $9.3m in warrant exercise deal
OncoSec Medical (NSDQ:ONCS) said yesterday that it inked a warrant exercise agreement with unnamed holders of outstanding warrants to buy up to 5.5 million shares of the company’s common stock at an exercise price of $1.69 apiece. The San Diego, Calif.-based company raised $9.3 million in gross proceeds from the exercise of the warrants, which it plans to […]
FDA clears Cianna Medical’s Savi Scout breast cancer locator for long term implants
Cianna Medical said today that the Savi Scout reflector, part of its system for wire-free breast tumor localization, won FDA clearance as the first non-radioactive implant without a restriction on the length of time that the reflector can remain in a patient’s breast. The new clearance means that doctors can place Scout to mark a […]
Q Biomed looks to dust off shelved cancer pain drug
Denis Corin has spent the last 13 years in the biopharmaceutical industry watching and learning from scientists and companies that fail. “I’ve seen so many promising and innovative young technologies really struggle along or die on the vine because they’re run by scientists who don’t really understanding capital raising,” he told Drug Delivery Business News. “They run […]
Augmenix touts AMA code, CMS reimbursement for SpaceOar
Augmenix said today that the American Medical Association established a Current Procedural Terminology code for its SpaceOar hydrogel and similar devices, with the Centers for Medicare and Medicaid Services setting a payment rate for procedures with the injectable. The Bedford, Mass.-based company said that the AMA established CPT code 55874 for the periprostatic implantation of biodegradable […]
7 medtech stories we missed this week: Nov. 3, 2017
From Hologic’s new product launch to CapsoVision gettting CE Mark approval, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Hologic launches new MyoSure device Hologic announced in a Nov. 1 press release that it has launched its MyoSure Manual Device in the U.S. The device is designed […]
Mauna Kea touts Cellvizio pancreatic cyst diagnosis study data
Mauna Kea (ENT:MKEA) today released data from a study exploring the use of the company’s Cellvizio system to diagnose pancreatic cysts, touting improved diagnoses and patient management. Results from the trial were presented at the United European gastroenterology Week 2017 meeting, the Paris-based company said. The Cellvizio device is designed for use in a variety of […]
Report: Doctor self-diagnoses cancer while testing Butterfly iQ ultrasound
A vascular surgeon was able to diagnose his own cancer while testing the Butterfly Network’s Butterfly iQ ultrasound-on-a-chip device, according to a report from USA Today. After experiencing some throat discomfort Dr. John Martin self-tested the device, designed to send images to and operate in conjunction with Apple (NSDQ:AAPL) iPhones, and found a mass that he […]
The top 10 medical disruptors of 2018
Each year the Cleveland Clinic determines what the top 10 disruptors in healthcare will be for the following year. The criteria to be considered a disruptor or innovation is that it has to be innovative and could change care in a significant way in the next year. Approximately 150 to 200 Cleveland Clinic physicians from […]
Lumicell raises $21m for image-guided cancer surgery tech
Lumicell has raised $20.7 million over the past three months, according to a regulatory document filed with SEC last week. More than 20 investors have contributed to the $26.5 million equity offering, the Wellesley, Mass.-based company reported, including one investor outside of the U.S. Get the full story at our sister site, Drug Delivery Business News.
Artificial intelligence could prevent breast cancer false positives: Here’s how
Artificial intelligence could improve detection and diagnosis of breast cancer and eliminate false positives, according to new research out of the Massachusetts Institute of Technology’s Computer Science and Artificial Intelligence Laboratory (CSAIL). A team of researchers from MIT’s CSAIL, Massachusetts General Hospital and Harvard Medical School developed an AI system with machine learning that can […]